AdaptHealth Q1 net loss widens to $16M, COO replaced; raises revenue guidance

AdaptHealth Corp.

2026-Q1 EPS reported -$0.12 revenue$819,799,000

Net revenue $819.8M (+5.4% YoY); net loss $16.0M vs $7.2M loss in Q1 2025.
Adjusted EBITDA $121.2M, down 5.3% YoY; free cash flow negative $27.5M.
FY 2026 net revenue guidance raised $10M to $3.45-3.52B; EBITDA and FCF guidance maintained.
COO Toby Scott Barnhart terminated May 4; replaced by Daniel McFadden (Chief Business Systems Officer).
Completed $1.1B refinancing in April, reducing near-term amortization and lowering average debt cost.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Daniel McFadden

Chief Operating Officer

AHCO · AdaptHealth Corp.

Effective: 2026-05-04
Filed: May 5, 2026, 7:59 PM ET

Also on May 4, 2026, the Company appointed Daniel McFadden, the Company’s current Chief Business Systems Officer, as the Company’s Chief Operating Officer.

Departed

Toby Scott Barnhart

Chief Operating Officer

AHCO · AdaptHealth Corp.

Effective: 2026-05-04
Successor: Daniel McFadden
Filed: May 5, 2026, 7:59 PM ET

On May 4, 2026, the Company terminated the employment of Toby Scott Barnhart, the Company’s Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AdaptHealth Corp. reported first quarter ended March 31, 2026 results: revenue $819.8 million, net income $16.0 million. Guidance raised.

Period: first quarter ended March 31, 2026
Revenue: $819.8 million
Net income: $16.0 million
Guidance: raised
Result: reported results

Exact text from the filing

the Company's portfolio around its core Sleep and Respiratory Health businesses. First Quarter Results All comparisons are to the quarter ended March 31, 2025. • Net revenue was $819.8 million compared to $777.9 million, an increase of 5.4%. • Organic revenue growth of 9.1%, with growth across each of the Company’s reportable segments. • Net loss attributable to

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel McFadden was appointed as Chief Operating Officer at AdaptHealth Corp..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

Also on May 4, 2026, the Company appointed Daniel McFadden, the Company’s current Chief Business Systems Officer, as the Company’s Chief Operating Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Toby Scott Barnhart was terminated as Chief Operating Officer at AdaptHealth Corp..

Action: terminated
Role: Chief Operating Officer

Exact text from the filing

On May 4, 2026, the Company terminated the employment of Toby Scott Barnhart, the Company’s Chief Operating Officer.

View on SEC.gov

18 earnings releases filed in the last 30 days. Browse all earnings releases →

AdaptHealth Corp. filing history →

Source: SEC EDGAR

accession 0001628280-26-030120

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.